Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

CSC

  • You have access
    Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells – Role of ABCG2
    FLORIAN SIMON, SABINA SCHWENK-ZIEGER, SVEN BECKER, KRISTIAN UNGER, OLIVIER GIRES and PHILIPP BAUMEISTER
    Anticancer Research March 2020, 40 (3) 1277-1284; DOI: https://doi.org/10.21873/anticanres.14069
  • You have access
    The Triple-negative Breast Cancer Cell Line MDA-MB 231 Is Specifically Inhibited by the Ionophore Salinomycin
    THOMAS HERO, HELMUT BÜHLER, PASCALINE NGUEMGO KOUAM, BETTINA PRIESCH-GRZESZOWIAK, TATIANA LATEIT and IRENÄUS ANTON ADAMIETZ
    Anticancer Research June 2019, 39 (6) 2821-2827; DOI: https://doi.org/10.21873/anticanres.13410
  • You have access
    AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes
    KENTA KURAMOTO, MASAHIRO YAMAMOTO, SHUHEI SUZUKI, TOMOMI SANOMACHI, KEITA TOGASHI, SHIZUKA SEINO, CHIFUMI KITANAKA and MASASHI OKADA
    Anticancer Research September 2018, 38 (9) 5093-5099; DOI: https://doi.org/10.21873/anticanres.12829
  • You have access
    Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas
    CECILIE GJØVAAG ATTRAMADAL, SHEEBA KUMAR, MORTEN E. BOYSEN, HARI PRASAD DHAKAL, JAHN MARTHIN NESLAND and MAGNE BRYNE
    Anticancer Research November 2015, 35 (11) 6111-6120;
  • You have access
    Primary Culture of Breast Cancer: A Model System for Epithelial-Mesenchymal Transition and Cancer Stem Cells
    TAKAHITO NISHIKATA, MAMI ISHIKAWA, TETSUHIRO MATSUYAMA, KAZUHIKO TAKAMATSU, TOSIYUKI FUKUHARA and YUTAKA KONISHI
    Anticancer Research July 2013, 33 (7) 2867-2873;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire